Mycobacterium mucogenicum Springer et al. (ATCC® 49651)

Strain Designations: MO135 [CDC 87-753]  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations MO135 [CDC 87-753]
Application
Characterization
Isolation
Post-injection site abscess, Texas
Type Strain no
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Name of Depositor RJ Wallace
Chain of Custody
ATCC <-- RJ Wallace <-- TS McHorse
Isolation
Post-injection site abscess, Texas
References

Band JD, et al. Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J. Infect. Dis. 145: 9-17, 1982. PubMed: 7054321

Springer B, et al. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov.. Int. J. Syst. Bacteriol. 45: 262-267, 1995. PubMed: 7537060

Wallace RJ Jr., et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J. Clin. Microbiol. 31: 3231-3239, 1993. PubMed: 8308116

Cross References

Nucleotide (GenBank) : X80772 Mycobacterium Chelonae-like organism 16S rRNA gene.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation